{
  "pmcid": "10638529",
  "sha256": "fcda6fc7da3d038cfb3775eed960b852c7ef3ba1238a659e7b72338a098648a6",
  "timestamp_utc": "2025-11-09T21:55:50.871960+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 9.048803708729082,
    "reading_ease": 46.46009837177749,
    "word_count": 201
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Autofluorescence in Thyroidectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients aged over 18 years undergoing total thyroidectomy were randomised 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients aged over 18 years undergoing total thyroidectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to either the intervention group using Fluobeam速 LX or a control group without it"
      },
      "Objective": {
        "score": 1,
        "evidence": "evaluated the use of Fluobeam速 LX for parathyroid gland visualization during total thyroidectomy to reduce postoperative hypoparathyroidism"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of low parathyroid hormone (PTH) levels on the first postoperative day."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using the Eurocrine速 platform with allocation concealed from patients."
      },
      "Blinding": {
        "score": 1,
        "evidence": "The study was single-blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between January 2021 and August 2022, 535 patients were randomised"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "535 patients were randomised, and 486 were analysed (246 intervention, 240 control)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The rate of low PTH levels was 26.0% in the intervention group and 32.1% in the control group (RR 0.81, 95% CI 0.61 to 1.07; p = 0.141)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No specific harm related to Fluobeam速 LX was reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04509011."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}